GOLDENWELL BIOTECH, INC. (GWLL) Net margin 2021–2025
GOLDENWELL BIOTECH, INC. (GWLL) net profit margin by fiscal year — reported net income divided by reported revenue.
-539038.2%FY2025 · since FY2021: -732.6% → -539038.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -539038.2% | -444435.3 pp |
| FY2024 | -94602.9% | -89587.5 pp |
| FY2023 | -5015.4% | -2954.6 pp |
| FY2022 | -2060.9% | -1328.2 pp |
| FY2021 | -732.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GWLL financial trends
GWLL RevenueGWLL Net incomeGWLL Gross profitGWLL Gross marginGWLL Operating incomeGWLL Operating marginGWLL Operating cash flowGWLL Free cash flowGWLL Capital expendituresGWLL Return on equityGWLL Stock buybacksGWLL Dividends paidGWLL Total assetsGWLL Total liabilitiesGWLL Shareholders’ equityGWLL overview →